KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

News: KZA Kazia Therapeutics Entered Licensing Agreement With Simcere Pharmaceutical Group Ltd

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    29/03/21
    19:20
    Post #: 52122950

    March 29 (Reuters) - Kazia Therapeutics Ltd (KZA) :

    • ENTERED INTO LICENSING AGREEMENT WITH SIMCERE PHARMACEUTICAL GROUP LTD
    • AGREEMENT TO DEVELOP AND COMMERCIALISE CO'S NEW DRUG, PAXALISIB, IN GREATER CHINA
    • UNDER TERMS OF AGREEMENT, KAZIA WILL RECEIVE AN UPFRONT PAYMENT OF US$11 MILLION
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.